Herbst Group LLC Invests in Eli Lilly and Company

New stake acquired in pharmaceutical giant

Apr. 5, 2026 at 9:06am

Got story updates? Submit your updates here. ›

Herbst Group LLC, an institutional investor, has acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the fourth quarter, according to a recent SEC filing. The fund purchased 1,925 shares of the pharmaceutical company's stock, valued at approximately $2,069,000.

Why it matters

Eli Lilly is one of the world's largest and most influential pharmaceutical companies, known for developing innovative drugs and therapies. This new investment by Herbst Group signals confidence in Lilly's future growth and performance, which could impact the stock price and investor sentiment.

The details

Herbst Group LLC's new stake in Eli Lilly and Company was disclosed in the fund's latest 13F filing with the SEC. The 1,925 shares acquired are valued at around $2.07 million based on Lilly's current stock price. Other major institutional investors have also recently modified their holdings in the company, including 10Elms LLP, M.E. Allison & CO. Inc., Bridgewater Advisors Inc., and Manske Wealth Management.

  • Herbst Group LLC acquired the new stake in Eli Lilly during the 4th quarter of 2025.

The players

Herbst Group LLC

An institutional investment firm that has acquired a new stake in Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana, known for developing innovative drugs and therapies.

Got photos? Submit your photos here. ›

The takeaway

This new investment by Herbst Group in Eli Lilly reflects ongoing confidence in the pharmaceutical company's growth potential and ability to deliver value for shareholders. As Lilly continues to innovate and expand its drug pipeline, its stock could see further upside in the coming years.